[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Daiichi Sankyo Company Limited

Daiichi Sankyo announces positive trial results for its oncology pipeline, but faces ongoing pricing and market access challenges for key drugs like Enhertu.

About Daiichi Sankyo Company Limited

Daiichi Sankyo Company Limited is a global pharmaceutical company focused on oncology.

Insights

Daiichi Sankyo Company Limited sentiment is up XXX% from the previous week.

Price: $

Price 24-Hour Time-Series Raw Data
Daiichi Sankyo stock fell XXX% due to an unchanged profit target and pricing/market access challenges, despite positive oncology pipeline news. Social posts also mention potential tariffs impacting Japanese-made drugs, which could further influence market sentiment.

1-Year High: $XXXXX on 2025-01-22
1-Year Low: $XXXXX on 2025-04-17

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Daiichi Sankyo Company Limited is currently AltRank #890 based on combined combined social and market metrics Daily Average: XXX
1-Year High: XXXXX on 2025-03-10
1-Year Low: XXX on 2025-01-21

Galaxy Score: XX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-02-25
1-Year Low: XX on 2025-07-21

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-03-31
1-Year Low: XX on 2025-01-09

Engagements by network (24h): Reddit: XX TikTok: X X: XXX YouTube: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX no change
X Month: XXX -XX%
X Months: XXX -XXXX%
X Year: XXXXX +109%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2024-12-16

Mentions by network (24h): Reddit: XX TikTok: X X: XX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Daiichi Sankyo Company Limited in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XXXX%
X Month: XX -XX%
X Months: XXX -XXXX%
X Year: XXX +117%
1-Year High: XX on 2025-07-04
1-Year Low: X on 2024-12-16

The most influential creators that mention Daiichi Sankyo Company Limited in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@ABNewswire	X	XXXXX	X	XX
@H2AK119ub	X	XXXXXX	X	XX
@newjerseyheadli	X	XXX	X	XX
@DaiichiSankyoUS	X	XXXXX	X	XX
@tom_the_bomb__	X	XXXXX	X	XX
@daiichisankyoeurope	X	XXX	X	X
@biotechtv	X	XXXXX	X	X

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +50%
X Month: XXX% no change
X Months: XXX% +27%
X Year: XXX% no change
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-02-01

Most Supportive Themes:

Oncology Pipeline Advancement: (40%) Daiichi Sankyo is making significant strides in its oncology pipeline, particularly with its antibody-drug conjugate (ADC) technology, leading to promising trial results and regulatory advancements.
Strategic Partnerships and Collaborations: (30%) The company is actively engaging in strategic partnerships, notably with AstraZeneca, to co-develop and commercialize innovative cancer treatments, enhancing its market position and R&D capabilities.
Market Expansion and Product Launches: (20%) Daiichi Sankyo is focused on expanding its market reach through new product launches and label expansions, as seen with Enhertu, indicating a strong commercial strategy and growing product portfolio.

Most Critical Themes:

Pricing and Market Access Challenges: (70%) Despite promising trial data, Daiichi Sankyo faces challenges related to pricing and market access for its key drugs, as highlighted by the NICE decision regarding Enhertu, which could impact adoption rates.
Competition in the Oncology Space: (30%) The oncology market is highly competitive, with numerous companies vying for market share. Daiichi Sankyo's success depends on maintaining its innovative edge and effectively differentiating its treatments.

Market Cap: $undefined

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXX on 2025-01-22
1-Year Low: $XXXXXXXXXXXXXXXXX on 2025-02-20